Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial (Q35736586)
Jump to navigation
Jump to search
scientific article published on 26 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial |
scientific article published on 26 April 2011 |
Statements
1 reference
Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial (English)
1 reference
David R Gandara
1 reference
George Somlo
1 reference
Ashkan Lashkari
1 reference
William Bellamy
1 reference
Todd M Zimmerman
1 reference
Joseph M Tuscano
1 reference
Margaret R O'Donnell
1 reference
Ann F Mohrbacher
1 reference
Stephen J Forman
1 reference
Paul Frankel
1 reference
Helen X Chen
1 reference
James H Doroshow
1 reference
26 April 2011
1 reference
1 reference
154
1 reference
4
1 reference
533-535
1 reference
Identifiers
1 reference
1 reference
1 reference